Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kassiou

Showing results (61-70 of 231) with videos related to

Pageof 24
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 6, 2008
Cubyl amides: novel P2X7 receptor antagonistsHendra Gunosewoyo, Jun Liu Guo, Maxwell R Bennett, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2012
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs)Samuel D Banister, Miral Manoli, Munikumar Reddy Doddareddy, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2011
Effects of linker elongation in a series of N-(2-benzofuranylmethyl)-N'-(methoxyphenylalkyl)piperazine σ₁ receptor ligandsIman A Moussa, Samuel D Banister, Fady N Akladios, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2011
Molecular hybridization of 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecane-3-ol with sigma (σ) receptor ligands modulates off-target activity and subtype selectivitySamuel D Banister, Iman A Moussa, William T Jorgensen, et al.
Neuropharmacology|February 18, 2021
Modulation of human T-type calcium channels by synthetic cannabinoid receptor agonists in vitroChris Bladen, Somayeh Mirlohi, Marina Santiago, et al.
Brain Research Bulletin|August 29, 2009
Oral pre-treatment with epigallocatechin gallate in 6-OHDA lesioned rats produces subtle symptomatic relief but not neuroprotectionKatherine R Leaver, Haydn N Allbutt, Nathan J Creber, et al.
Psychopharmacology|March 13, 2015
WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist actionCallum Hicks, Linnet Ramos, Tristan A Reekie, et al.
Biotechnology and Bioengineering|July 3, 2023
Three-dimensional bioprinting of stem cell-derived central nervous system cells enables astrocyte growth, vasculogenesis, and enhances neural differentiation/functionMichael A Sullivan, Samuel Lane, Alexander Volkerling, et al.
Trends in Pharmacological Sciences|December 5, 2018
Targeting the Oxytocin System: New Pharmacotherapeutic ApproachesDamien Gulliver, Eryn Werry, Tristan A Reekie, et al.
Neuroscience Letters|March 7, 2007
Decreased vesicular acetylcholine transporter and alpha(4)beta(2) nicotinic receptor density in the rat brain following 192 IgG-saporin immunolesioningMitchell Quinlivan, Sylvie Chalon, Jackie Vergote, et al.
Pageof 24

Showing results (61-70 of 231) with videos related to

Sort By:
Pageof 24
Bioorganic & Medicinal Chemistry Letters|June 6, 2008
Cubyl amides: novel P2X7 receptor antagonistsHendra Gunosewoyo, Jun Liu Guo, Maxwell R Bennett, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2012
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs)Samuel D Banister, Miral Manoli, Munikumar Reddy Doddareddy, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2011
Effects of linker elongation in a series of N-(2-benzofuranylmethyl)-N'-(methoxyphenylalkyl)piperazine σ₁ receptor ligandsIman A Moussa, Samuel D Banister, Fady N Akladios, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2011
Molecular hybridization of 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecane-3-ol with sigma (σ) receptor ligands modulates off-target activity and subtype selectivitySamuel D Banister, Iman A Moussa, William T Jorgensen, et al.
Neuropharmacology|February 18, 2021
Modulation of human T-type calcium channels by synthetic cannabinoid receptor agonists in vitroChris Bladen, Somayeh Mirlohi, Marina Santiago, et al.
Brain Research Bulletin|August 29, 2009
Oral pre-treatment with epigallocatechin gallate in 6-OHDA lesioned rats produces subtle symptomatic relief but not neuroprotectionKatherine R Leaver, Haydn N Allbutt, Nathan J Creber, et al.
Psychopharmacology|March 13, 2015
WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist actionCallum Hicks, Linnet Ramos, Tristan A Reekie, et al.
Biotechnology and Bioengineering|July 3, 2023
Three-dimensional bioprinting of stem cell-derived central nervous system cells enables astrocyte growth, vasculogenesis, and enhances neural differentiation/functionMichael A Sullivan, Samuel Lane, Alexander Volkerling, et al.
Trends in Pharmacological Sciences|December 5, 2018
Targeting the Oxytocin System: New Pharmacotherapeutic ApproachesDamien Gulliver, Eryn Werry, Tristan A Reekie, et al.
Neuroscience Letters|March 7, 2007
Decreased vesicular acetylcholine transporter and alpha(4)beta(2) nicotinic receptor density in the rat brain following 192 IgG-saporin immunolesioningMitchell Quinlivan, Sylvie Chalon, Jackie Vergote, et al.
Pageof 24